Limoges hospital
Limoges, 87 042, France
NCT Number: NCT02675504
Since the 2000s, the experiences of children and especially their fear during a consultation, a treatment or examination is food for thought in our establishment. There is no tool validated self-assessment of fear to 6 faces. It therefore appeared necessary to us to create this tool. The scale self-assessment of the fear that we have developed consists of six faces representing a gradual level of fear: the child can easily describe their level of fear, which allows for appropriate care.
Looking for future studies?
Notify Me4 year–12 year
All sexes
Observational
Limoges, 87 042, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Children spend a self-assessment scale of fear
Time frame: 5 minutes
Percentage of children who validate the 6 faces expressing fear. The test will be validated if we get a result at least 60%.
Time frame: 5 minutes
University Hospital, Limoges
Other
Validation of a Scale of Self-assessment of Fear Faces in Children 4 to 12 Years: Scary Scale
Acronym: TROUILLOMETRE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07739381
Anxiety, Anxiety Disorders
Kütahya, Turkey (Türkiye)
View Trial DetailsNCT06510166
Anxiety, Anxiety Disorders
Samsun, Atakum, Turkey (Türkiye)
View Trial DetailsNCT07255365
Anxiety, Anxiety Disorders
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07667920
Anxiety, Anxiety Disorders
Istanbul, Turkey (Türkiye)
View Trial Details